Data

Prophylaxis of organ rejection market is expected to gain market growth in the forecast period of 2020 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 4.4% in the forecast period of 2022 to 2029 and is expected to reach USD 3,894.40 million by 2029 from USD 2,781.83 million in 2021 Industry Analysis The term prophylaxis means treatment given or action taken to prevent disease. The prophylaxis of organ rejection, refers to the prevention of organ rejection by use of medicines. The patients who undergo transplantation, must be maintained on an immunosuppression regimen for rejection prophylaxis to help ensure graft survival. The transplant rejection is a process, in which a transplant recipient’s immunity the current rejection prophylaxis implements use of calcineurin inhibitors, mTOR inhibitors, antimetabolite agents, and corticosteroids. The treatment agents improve the short term consequences of the organ transplantation, but certain improv...